Sector

Patenting known substances: The problem with polymorphs

In nature, every molecule rearranges itself into different crystalline forms or shapes. Unsurprisingly, the ability of a molecule to mimic without losing its basic properties took the interest of such molecules into the helms of industrial and pharma...

Is Section 3(d) of India’s Patents Act a workable provision? The long-term effect.

On April 1, 2013, the Supreme Court of India delivered a landmark decision in the Novartis Glivec case on the interpretation of Section 3(d) of the Indian Patents Act.

Computational data analysis exception in Singapore’s Copyright Act 2021 a game changer

The life of the IP lawyer in the ‘new normal’

countries around the region are figuring out how to handle the coronavirus long-term, as many are beginning to open up again

The rise of IP rights and data privacy in a pandemic

speaking with two Baker McKenzie lawyers about the intersection of the pandemic, IP and data privacy.

IP rights: To forego or not to forego?

reporting that not everyone is convinced that would work as intended.

Innovation and IP is Key to Sustainability

A New Interview Approach Develops Under Taiwan’s Patent System

Duo Charged With Selling Trade Secrets To China.

2021 Asia IP Patent Rankings

The results of the 2021 Asia IP Patent survey are revealed. Who are Asia’s leading firms?

South Korea's IP Experts

Taiwan's IP Experts

Intellectual property strategies for India

Having a strong intellectual property strategy is essential to long-term protection of your IP rights. Pravin Anand shares some of his firm’s most successful strategies.

Right to cross-examination of an expert witness: Absolute or discretionary?

Cross-examination is an excellent tool in the hands of expert lawyers, particularly in contested patent cases to find the veracity of the expert or demolish the correctness of the technical position taken by the experts. D.P.S. Parmar examines the us...

Cambodia Enters Into Bilateral Agreements With Major Patent Offices